Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS068 (Insulin Sudelidec) vs Insulin Glargine in T2DM Not Controlled with Basal Insulin
NCT05702073Phase 3Completed
- Sponsor
- Hengrui
- Start
- Mar 2023
- Primary completion
- Jun 2024
- Modality
- Peptides, Insulin and Analogs
- Countries
- 1
01
Overview
A Phase 3 trial of insulin sudelidec in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Started Mar 2023; status: completed.
02
Drugs
insulin sudelidec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05702073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702073.